SEC Form 4 · accession 0001209191-17-044460
Juno Therapeutics, Inc. · JUNO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anthony B Evnin
Director
Period of report
Jul 5, 2017
Accepted (ET)
Jul 7, 2017 · 7:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001594864
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 5, 2017 | A | 230 | $0.00 | A | 66,531 | D | |
| Common StockF1 | Jul 6, 2017 | G | 7,000 | $0.00 | D | 59,531 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a bona fide gift of common stock; thus, there is no price associated with this transaction.